A | B | C | D | E | F | G | H | CH | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 0 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9
Charles Swanton | |
---|---|
![]() Swanton in 2018 | |
Born | Robert Charles Swanton 1972 (age 51–52)[2] |
Education | St Paul's School, London |
Alma mater | University College London (MD, PhD) |
Awards | Ellison–Cliffe Lecture (2017) EMBO Member (2017) |
Scientific career | |
Fields | Cancer evolution[1] |
Institutions | Francis Crick Institute University College London |
Thesis | Viral cyclin disruption of mammalian cell cycle control mechanisms (1998) |
Doctoral advisor | Nic Jones |
Website | www |
(Robert) Charles Swanton FRS FMedSci FRCP is British physician scientist specialising in oncology and cancer research. Swanton is a senior group leader at London's Francis Crick Institute,[3] Royal Society Napier Professor in Cancer[4] and thoracic medical oncologist at University College London[5] and University College London Hospitals,[6][7] co-director of the Cancer Research UK (CRUK) Lung Cancer Centre of Excellence, and Chief Clinician of Cancer Research UK.[8][9]
Early life and education
![]() | This section needs expansion. You can help by adding to it. (June 2024) |
Swanton was born in Poole, Dorset. As of 2017, his father Robert Howard Swanton (MD, FRCP) was a consultant cardiologist at UCL.[10]
Swanton was educated at St Paul's School, London[2] and completed his PhD in 1999[11] at what was then the Imperial Cancer Research Fund Laboratories (now the Francis Crick Institute) and his Cancer Research UK clinician scientist/medical oncology training in 2008.[7]
Career
![](http://upload.wikimedia.org/wikipedia/commons/thumb/4/45/Professor_Charles_Swanton.jpg/220px-Professor_Charles_Swanton.jpg)
Swanton has combined [when?] his laboratory research with clinical duties as co-director of the CRUK Lung Cancer Centre, focussed on how tumours evolve over space and time.[7] He has helped to define the branched evolutionary histories of solid tumours, processes that drive cancer cell-to-cell variation in the form of new cancer mutations or chromosomal instabilities, and the impact of such cancer diversity on effective immune surveillance and clinical outcome.[1][7][12][13]
As of 2018, Swanton has been a co-founder of Achilles Therapeutics[14] with Sergio Quezada, Karl Peggs and Mark Lowdell. Achilles Therapeutics is a UCL/CRUK and Francis Crick Institute[15] biotechnology company funded by Syncona[16] that develops adoptive T cell therapies targeting clonal/truncal neo-antigens present in every tumour cell to limit drug resistance and tumour evolution.[citation needed]
Awards and honours
- 1997: Imperial Cancer Research Fund's (ICRF) Pontecorvo PhD thesis prize[17]
- 2011: Fellow of the Royal College of Physicians (FRCP)[citation needed]
- 2014: Jeremy Jass Prize in pathology
- 2015: Fellow of the Academy of Medical Sciences (FMedSci)[18]
- 2015: Stand up to Cancer Translational Cancer Research Prize
- 2016: Glaxo Smithkline Biochemical Society Prize[citation needed]
- 2016: San Salvatore prize for Cancer Research[19]
- 2017: CRUK Translational Research Prize in 2017,[20]
- 2017: EMBO Member in 2017[21]
- 2017: Ellison-Cliffe Medal by the Royal Society of Medicine
- 2018: Elected a Fellow of the Royal Society (FRS)[7]
- 2018: Massachusetts General Hospital Cancer Centre Kraft Prize[22]
- 2018: Gordon Hamilton Fairley Medal and Lecture[7][23]
- 2019: ESMO Translational Research Award
- 2020: Addario Lung Cancer Foundation Award and Lecture
- 2021: Weizmann Institute - Sergio Lambroso Award in Cancer Research
- 2021: Paul Marks Prize for Cancer Research
Personal life
![]() | This section needs expansion. You can help by adding to it. (June 2024) |
References
- ^ a b Charles Swanton publications indexed by Google Scholar
- ^ a b c Anon (2017). "Swanton, Prof. (Robert) Charles". Who's Who (online Oxford University Press ed.). Oxford: A & C Black. doi:10.1093/ww/9780199540884.013.U286524. (Subscription or UK public library membership required.)
- ^ "Charles Swanton – The Francis Crick Institute". crick.ac.uk.
- ^ Anon (2016). "Leading scientists awarded Royal Society Research Professorships". royalsociety.org. Royal Society. Retrieved 27 November 2018.
- ^ "Iris View Profile". iris.ucl.ac.uk. Archived from the original on 22 May 2017. Retrieved 12 January 2022.
- ^ "The UCLH lung cancer service". uclh.nhs.uk. Retrieved 27 November 2018.
- ^ a b c d e f Anon (2018). "Professor Charles Swanton FMedSci FRS". London: Royal Society. One or more of the preceding sentences incorporates text from the royalsociety.org website where:
"All text published under the heading 'Biography' on Fellow profile pages is available under Creative Commons Attribution 4.0 International License." --"Terms, conditions and policies | Royal Society". Archived from the original on 11 November 2016. Retrieved 27 June 2018.
{{cite web}}
: CS1 maint: bot: original URL status unknown (link) - ^ "Chief Executive and Executive Board". 27 September 2013.
- ^ Charles Swanton publications from Europe PubMed Central
- ^ Anon (2017). "Swanton, Robert Howard". Who's Who (online Oxford University Press ed.). Oxford: A & C Black. doi:10.1093/ww/9780199540884.013.U4000216. (Subscription or UK public library membership required.)
- ^ Swanton, Robert Charles (1998). Viral cyclin disruption of mammalian cell cycle control mechanisms. london.ac.uk (PhD thesis). University College London (University of London). OCLC 941060556. EThOS uk.bl.ethos.286205.
- ^ Swanton, Charles; Mann, David J.; Fleckenstein, Bernhard; Neipel, Frank; Peters, Gordon; Jones, Nic (1997). "Herpes viral cyclin/Cdk6 complexes evade inhibition by CDK inhibitor proteins". Nature. 390 (6656): 184–187. Bibcode:1997Natur.390..184S. doi:10.1038/36606. ISSN 0028-0836. PMID 9367157. S2CID 4397584.
- ^ Charles Swanton publications indexed by the Scopus bibliographic database. (subscription required)
- ^ "Our Team – Achilles Therapeutics". achillestx.com. Retrieved 27 November 2018.
- ^ UCL (5 October 2016). "UCL spin-out Achilles Therapeutics to develop immunotherapies for cancer". UCL News. Retrieved 27 November 2018.
- ^ "Achilles Therapeutics". Syncona. Retrieved 27 November 2018.
- ^ "Pontecorvo Prize for best PhD thesis". cancerresearchuk.org. 28 October 2015. Retrieved 27 November 2018.
- ^ "Professor Charles Swanton – The Academy of Medical Sciences". acmedsci.ac.uk. Retrieved 27 November 2018.
- ^ Systems, eZ. "List of Award Winners / Fondazione San Salvatore". fondazionesansalvatore.ch. Archived from the original on 22 July 2018. Retrieved 27 November 2018.
- ^ "Translational Cancer Research Prize". cancerresearchuk.org. 28 October 2015. Retrieved 27 November 2018.
- ^ Jukic, Igor. "EMBO welcomes 65 new members". Embo.org. Archived from the original on 27 September 2017. Retrieved 27 November 2018.
- ^ "Kraft Prize Symposium – Massachusetts General Hospital, Boston, MA". massgeneral.org. Retrieved 27 November 2018.
- ^ Azvolinsky, Anna (2018). "Cancer Evolutionist: A Profile of Charles Swanton". The Scientist.
This article incorporates text available under the CC BY 4.0 license.
Text je dostupný za podmienok Creative Commons Attribution/Share-Alike License 3.0 Unported; prípadne za ďalších podmienok. Podrobnejšie informácie nájdete na stránke Podmienky použitia.
Antropológia
Aplikované vedy
Bibliometria
Dejiny vedy
Encyklopédie
Filozofia vedy
Forenzné vedy
Humanitné vedy
Knižničná veda
Kryogenika
Kryptológia
Kulturológia
Literárna veda
Medzidisciplinárne oblasti
Metódy kvantitatívnej analýzy
Metavedy
Metodika
Text je dostupný za podmienok Creative
Commons Attribution/Share-Alike License 3.0 Unported; prípadne za ďalších
podmienok.
Podrobnejšie informácie nájdete na stránke Podmienky
použitia.
www.astronomia.sk | www.biologia.sk | www.botanika.sk | www.dejiny.sk | www.economy.sk | www.elektrotechnika.sk | www.estetika.sk | www.farmakologia.sk | www.filozofia.sk | Fyzika | www.futurologia.sk | www.genetika.sk | www.chemia.sk | www.lingvistika.sk | www.politologia.sk | www.psychologia.sk | www.sexuologia.sk | www.sociologia.sk | www.veda.sk I www.zoologia.sk